Benchmark Reiterates Hold Rating on Neogenomics (NEO) on 2025 Revenue Guidance
Go back to Benchmark Reiterates Hold Rating on Neogenomics (NEO) on 2025 Revenue Guidance| NEOGENOMICS (NASDAQ: NEO) | Delayed: 16.16 +0.22 (1.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.94 | 52 Week High | $9.54 | |||
| Open | $15.72 | 52 Week Low | $5.49 | |||
| Day High | $16.36 | P/E | 404.00 | |||
| Day Low | $15.72 | EPS | $0.04 | |||
| Volume | 1,137,478 | |||||

